The Industrialist's Dilemma: Alex Gorsky, Chairman and CEO of Johnson & Johnson

TL;DR

Johnson & Johnson's CEO discusses the company's success driven by its diverse business model and the importance of embracing new technology in the healthcare industry.

Transcript

[MUSIC] Alex Gorsky, CEO of Johnson & Johnson welcome to the Industrials Dilemma. >> Hey, Rob, it's great to be here. >> Thank you so much for coming. What I'd like to ask you first is tell us a little bit about the business. You've got three major product groups right, medical devices, pharmaceuticals and consumer products. How do you deal with ma... Read More

Key Insights

• 👨‍💼 Diversity of businesses has been a significant driver for Johnson & Johnson's success over the past 132 years.
• 🪛 Advancements in science and technology, driven by digital technology and data analytics, are transforming the healthcare industry.
• 😨 The challenge of balancing the cost of healthcare with the demand for high-quality, value-based care is a crucial consideration for companies like Johnson & Johnson.
• ⚾ Evolving reimbursement systems and focusing on prevention and outcome-based approaches are essential in meeting healthcare challenges.
• 🙈 Johnson & Johnson sees partnerships and collaborations as opportunities to learn, gain access to new technologies, and reach more patients and consumers.
• 😶‍🌫️ The company's use of cloud capabilities enables effective data analysis, pooling of information, and personalized engagement with consumers.
• 🎁 The CEO acknowledges the complexities and opportunities presented by external forces, requiring constant strategic adaptation and evolution.

Questions & Answers

Q: How does Johnson & Johnson manage the complexity of its three major product groups?

Johnson & Johnson embraces its diverse business model and believes in going where the best opportunities are in pharmaceuticals, medical devices, and consumer products. Their success lies in their ability to bring technology, capabilities, and global reach to help patients and consumers.

Q: How is data changing the way Johnson & Johnson does business?

Data plays a vital role in Johnson & Johnson's business, particularly in areas like diagnostics, oncology, and robotics. Data enables early detection of diseases, better understanding of the human immune system, and real-time feedback in surgical procedures. It helps them provide targeted, personalized treatments and improve products and experiences for consumers.

Q: How does Johnson & Johnson utilize cloud capabilities in their business?

Cloud capabilities allow Johnson & Johnson to gather and analyze vast amounts of data in their pharmaceutical, medical device, and consumer businesses. It helps them pool information for better diagnostics, gather real-world usage data, and engage with consumers. Cloud technology has become essential in their transformation into a healthcare technology company.

Q: How does Johnson & Johnson approach partnerships and collaborations?

Johnson & Johnson believes in both internal and external innovation. They partner externally about 50% of the time, striving to find the best science and technology. They actively build relationships with academic centers, venture communities, and startups to stay at the cutting edge of science. They bring their expertise and resources to external technologies, helping them grow and reach more patients and consumers.

Summary & Key Takeaways

• Johnson & Johnson's CEO highlights the company's success being driven by its diverse business model, allowing them to participate in various opportunities within pharmaceuticals, medical devices, and consumer products.

• The CEO talks about the exciting advancements in science and technology in the healthcare industry, such as the potential for early detection of diseases and the use of data analytics for better diagnostics and personalized treatments.

• He emphasizes the need for data and digital technology in all sectors of the company, including pharmaceutical, medical devices, and consumer products.